학술논문

PL02.11 Overall Survival with Durvalumab Plus Etoposide-Platinum in First-Line Extensive-Stage SCLC: Results from the CASPIAN Study
Document Type
Abstract
Source
In Journal of Thoracic Oncology October 2019 14(10) Supplement:S7-S8
Subject
Language
ISSN
1556-0864